News from the FDA/CDC
News from the FDA/CDC
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
News from the FDA/CDC
CDC data strengthen link between obesity and severe COVID
Progressively intensive management of COVID-19 might be needed for patients with more severe obesity.
FDA/CDC
FDA authorizes first molecular at-home, OTC COVID-19 test
The Cue OTC Test is the first molecular diagnostic test available to consumers without a prescription.
News from the FDA/CDC
J&J COVID-19 vaccine wins unanimous backing of FDA panel
The Johnson & Johnson vaccine is expected to offer more convenient dosing and be easier to distribute than the two rival products already...
News from the FDA/CDC
FDA approves first targeted treatment for rare DMD mutation
This particular mutation of the DMD gene “is amenable to exon 45 skipping.”
News from the FDA/CDC
Variants spur new FDA guidance on COVID vaccines, tests, drugs
The FDA has already been communicating with individual manufacturers as they assess the variants’ effect on their products.
News from the FDA/CDC
CDC chief lays out attack plan for COVID variants
Public health leaders are ramping up genome sequencing of the SARS-CoV-2 virus and ensuring that sampling is geographically representative.
News from the FDA/CDC
CDC panel: No COVID-19 vaccine safety surprises
News from the FDA/CDC
CDC issues COVID-19 vaccine guidance for underlying conditions
The CDC guidance had specific information for people with ...
News from the FDA/CDC
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
The primary safety endpoint was to characterize the safety of the vaccine following one or two doses.
News from the FDA/CDC
Vaccine rollout on track, expect 300 million doses through March: Feds
Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the U.S. by March 31.